NCT01182376View on ClinicalTrials.gov

SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Atrial Fibrillation
Interventions
DRUG

dronedarone

Dronedarone will be prescribed by the patient's team according to established guidelines.

DRUG

Placebo

Placebo will be administered by the patient's team according to established guidelines.

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Utah

OTHER